The following scientific articles have resulted from collaborative work performed by members of the various Working Groups of the Genomic Medicine Alliance and listed below in chronological order:



Patrinos GP, et al. (2013). Genetic tests obtainable through pharmacies: The good the bad and the ugly. Hum Genomics 7:17.   



Cooper DN, et al. (2014). Bridging genomics research between developed and developing countries: The Genomic Medicine Alliance. Per Med 11(7): 615-623.  

Dalabira E, et al. (2014). An online resource triangulating drugs with genes and biomarkers for clinical pharmacogenomics. Public Health Genomics 17(5-6): 265-271.

Kechagia S, et al. (2014). Personal Genomics in Greece: An Overview of Available Direct-to-Consumer Genomic Services and the Relevant Legal Framework. Public Health Genomics 17(5-6): 299-305. 

Mitropoulou C, et al. (2014). Documentation and analysis of the policy environment and key stakeholders in pharmacogenomics and genomic medicine in Greece. Public Health Genomics 17(5-6): 280-286.    

Mizzi C, et al. (2014). Personalized pharmacogenomics profiling using whole genome sequencing. Pharmacogenomics, 15(9): 1223-1234. 

Pisanu C, et al. (2014). Assessment of the Pharmacogenomics Educational Environment in Southeast Europe. Public Health Genomics 17(5-6): 272-279.     

Snyder SR, et al. (2014). Economic evaluation of pharmacogenomics: a value-based approach to pragmatic decision making in the face of complexity. Public Health Genomics 17(5-6): 256-264.  



Karageorgos Ι, et al. (2015). Identification of cancer predisposition variants using a next generation sequencing-based family genomics approach. Hum Genomics. 9: 12.

Mitropoulos K, et al. (2015). Success stories in genomic medicine from resource-limited countries. Hum Genomics 9: 11.



Mizzi C, et al. (2016). A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics. PLoS One. 11(9): e0162866. 

Vozikis A, et al. (2016). Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy. Public Health Genomics 19(6): 352-363. 



Balasopoulou A, et al. (2017). Advancing Global Precision Medicine: An Overview of Genomic Testing and Counseling Services in Malaysia. OMICS 21(12): 733-740. 

Mitropoulos K, et al. (2017). Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy. OMICS 21(11): 647-657.

Sarris K, et al. (2017). Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics. Public Health Genomics 20(2): 142-147.

Viennas E, et al. (2017). Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies. Nucleic Acids Res 45(D1): D846-D853. 

Become a Member

You just have to register your personal details to activate your membership to the Genomic Medicine Alliance.
Membership is FREE-OF-CHARGE.

Become a Member

Want to work with us?
Become a Member